Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$25.04 - $30.06 $249,523 - $299,547
-9,965 Reduced 83.04%
2,035 $228,000
Q1 2019

May 01, 2019

BUY
$20.23 - $26.29 $242,760 - $315,480
12,000 New
12,000 $292,000
Q4 2018

Feb 13, 2019

SELL
$17.64 - $28.32 $168,462 - $270,456
-9,550 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $197,112 - $245,148
9,550 New
9,550 $246,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.59B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.